No GIST-type c-kit gain of function mutations in neuroblastic tumours

Aims: Neuroblastic tumours (NTs) have been shown to respond to imatinib treatment in vivo and in vitro, possibly via inactivating the c-kit receptor. The purpose of this study was to identify gastrointestinal stromal tumour (GIST)-type c-kit gene associated mutations in exons 9, 11, 13, and 17 in NT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Korja, M, Finne, J, Salmi, T T, Haapasalo, H, Tanner, M, Isola, J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Copyright 2005 Journal of Clinical Pathology 2005
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1770714/
https://ncbi.nlm.nih.gov/pubmed/15976348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2004.024331
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge